MRC1 and cancer: It was previously shown that cancer-free MMR-deficient and MMR-proficient non-polyposis hereditary cases show distinct patterns of blood telomere lengths (19), suggesting the importance of the MMR system’s status on telomere length in hereditary cases, and that a genetic variant in the telomerase gene can modify the cancer risk in Lynch carriers (20).